Q4 2025 Canopy Growth Corp Earnings Call Transcript
Key Points
- Canopy Growth Corp (CGC) has unified its global medical cannabis businesses to improve speed, scalability, and market responsiveness, leading to a 13% growth in the Canadian medical business.
- The company has streamlined its Canadian adult-use business by removing low-performing SKUs and focusing on high-margin products, which has strengthened relationships with key accounts.
- Canopy Growth Corp (CGC) has established a centralized global operations function to enhance supply and demand planning, resulting in improved fill rates from mid-80s to mid-90s.
- The company has identified $20 million in cost reductions, with 80% of savings already identified and over 50% executed, creating financial flexibility for reinvestment.
- Canopy Growth Corp (CGC) has made a USD100 million early prepayment on its senior secured term loan, reducing annual interest expenses by approximately USD13 million.
- Q4 fiscal '25 results fell short of expectations due to lower revenue in Storz & Bickel, Poland, and Australian medical businesses.
- Free cash flow was an outflow of $36 million for Q4, compared to an outflow of $23 million a year ago, due to higher capex and increased working capital.
- International markets cannabis sales declined 35% in Q4 fiscal '25 compared to Q4 fiscal '24, with significant drops in Poland and Australia.
- Storz & Bickel experienced a 23% year-over-year revenue decline in Q4, with continued softness into Q1 fiscal '26 due to decreased vaporizer demand.
- Acreage's performance was negatively impacted by liquidity challenges and underperformance in the Ohio adult-use cannabis market, affecting Canopy USA's revenue expectations.
Good morning. My name is [Joanna]. I will be a conference operator today. I would like to welcome you to Canopy Growth's fourth quarter and fiscal year 2025 financial results conference call. (Operator Instructions) I will now turn the call over to Tyler Burns, Director of Investor relations. Tyler, you may begin the conference call.
Good morning and thank you for joining us. On our call today, we have Canopy Growth's Chief Executive Officer Luc Mongeau, and Chief Financial Officer Judy Hong. Before financial markets opened today, Canopy Growth issued a news release announcing the financial results for our fourth quarter and fiscal year 2025 ended March 31, 2025.
The news release and financial statements have been filed on EDGAR and CEDAR and will be available on our website under the investor tab. Before we begin, I would like to remind you that our discussion during this call will include forward-looking statements that are based on management's current views and assumptions, and that
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

